8-K ·Filed Aug 19, 2026

NVST

Envista Holdings Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago SEC0001757073-26-000074
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

Monitor next quarterly earnings for any strategic or operational updates that may have prompted the board consolidation. The compensation changes are retention-focused and signal board alignment with management, but provide no near-term trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
NVST ▼ -14.10% at T+20d
NEUTRAL call ✗ call lost -14.10% · α vs SPY -12.15% · entry $27.58 → $23.69
Next anchor: T+60d in 6w
Latest observation: T+29 -14.49% FF3 residual α
Entry anchored
Aug 18, 04:32 PM ET
via 1-min bar
T+1d
-2.36%
call -2.36% · α -1.52%
$26.93
settled 6w ago
T+5d
+0.80%
call +0.80% · α +1.19%
$27.80
settled 5w ago
T+20d
-14.10%
call -14.10% · α -12.15%
$23.69
settled 15d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Envista Holdings appointed CEO Paul Keel as Chairman of the Board and granted him a $10M special equity award ($5M RSUs + $5M PSUs) plus a $200K base salary increase. CFO Eric Hammes received a $1.5M special PSU award. These are routine governance and compensation changes with no material financial data or operational updates — the filing is neutral and low-impact.

Key Facts

  • CEO Paul Keel appointed Chairman of the Board, effective August 19, 2026
  • Scott Huennekens remains as director and Lead Independent Director
  • CEO base salary increased by $200K to $1.3M/year
  • CEO granted $10M special equity award ($5M RSUs + $5M PSUs)
  • CFO Eric Hammes granted $1.5M special PSU award
  • All equity awards vest over four years with TSR-based performance conditions

Financial Impact

CEO salary increase of $200K/year; CEO equity award of $10M; CFO equity award of $1.5M — total incremental annual compensation cost of approximately $200K cash plus $11.5M in equity (one-time)

compensation expensediluted share count

Risk Factors

  • No financial or operational data provided — compensation changes alone are not a trading signal
  • CEO combining Chairman role reduces board independence, though Lead Independent Director role mitigates this

Market Snapshot

Exchange
NYSE
Sector
Dental Equipment & Supplies
Analyst Consensus
55% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001757073-26-000074
Document: 0001757073-26-000074-index-headers.html0001757073-26-000074
Document: 0001757073-26-000074-index.html0001757073-26-000074
Document: 0001757073-26-000074.txt0001757073-26-000074
3 reports for NVST
Performance horizon
Filters
Rows
Reports for NVST — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$27.58 $23.69▼ −14.10%▼ −12.15%$23.46 (−14.94%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$22.87 $27.63▲ +20.81%▲ +22.19%$23.46 (+2.58%)
Apr 7, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$26.66 $26.19▼ −1.76%▼ −10.31%$23.46 (−12.00%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access